Anavex Life Sciences Corp (AVXL)

[drv17]

Power and Bas - Fred Knoll has 5.03% of Knoll Capital Management's funds invested in Anavex as of 12/31/2016, not 5% of Anavex's market cap.

Home > Hedge Funds > Knoll Capital Management > Profile
Hedge Fund - Knoll Capital Management
Get Email Alerts
ProfileHoldingsLatest 13D & 13G FilingsNews, Interviews, and Investor Letters
Fred Knoll Bio, Returns, Net Worth
Fred Knoll has led Knoll Capital Management since 1987, and he personally manages Knoll Capital Fund I and Knoll Capital Fund II. Fred Knoll had previously worked with Telos Corporation, General American Investors, Murray Johnstone, and Robert Fleming. He studied at M.I.T. and got his M.B.A. from Columbia University, and his fund focuses on technology stocks.

Share0 Tweet2
0 Share38
image: http://cdn1.insidermonkey.com/manager-images/no-pic.2014-03-02.png

Fred Knoll
Fund ProfileFiling Period:
Fund Name: Knoll Capital Management
Manager Fred Knoll
Portfolio Value $56,996,000
Change This QTR +1.00%
image: http://chart.apis.google.com/chart?cht=p&chd=t:13.27,86.65&chs=300x120&chl=Healthcare|Other&&chco=CB3A1B

Fund Holdings Sector Distribution
Top HoldingsLogin to See All Holdings | Sign up
Filing Period:
Last updated on February 14, 2017, 5:07 pm based on SEC 13F filings
No. Security Ticker Shares Value (x$1000) Activity % Port
1.
Corbus Pharmaceuticals Hldgs
2,563,925 $21,665 38.01%
2.
Abeona Therapeutics Inc
2,359,767 $11,445 +74% 20.08%
3.
Vascular Biogenics Ltd
860,605 $4,174 7.32%
4.
Anavex Life Sciences Corp
724,205 $2,868 5.03%

Read more at http://www.insidermonkey.com/hedge-fund/knoll+capital+management/466/#p1SHpScUXtXzrlMT.99